Mining
Business
Investments
Bitcoin
Trading
Markets
Blockchain
Home
»
Novartis AG (NVS) Discusses REMODEL Trial Results for Remibrutinib in Relapsing Multiple Sclerosis – Slideshow
Novartis AG (NVS) Discusses REMODEL Trial Results for Remibrutinib in Relapsing Multiple Sclerosis – Slideshow
October 24, 2026
October 24, 2026
Bitcoin (BTC)
$
80,884.00
Ethereum (ETH)
$
2,380.92
Tether (USDT)
$
0.999097
XRP (XRP)
$
1.29
BNB (BNB)
$
739.51
Dogecoin (DOGE)
$
0.078848
Solana (SOL)
$
102.51
USDC (USDC)
$
0.999735
Lido Staked Ether (STETH)
$
2,265.05
Avalanche (AVAX)
$
9.04
TRON (TRX)
$
0.329709
Wrapped stETH (WSTETH)
$
2,779.67
Sui (SUI)
$
0.962702
Chainlink (LINK)
$
11.86
WETH (WETH)
$
2,268.37
Polkadot (DOT)
$
1.09